Tender detail
Conclusion of non-exclusive discount agreements for medicines containing pancreatin under an open-house model
Summary
The procurement concerns non-exclusive pharmaceutical discount agreements for medicines containing pancreatin (WHO ATC code A09AA02), concluded under an open-house model. Purchase volumes depend on demand and are not guaranteed; no minimum quantities are specified. The agreements end no later than 31 October 2027, although the procedure may be terminated earlier, including if exclusive discount agreements are concluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.